Target Name: CACNA1B
NCBI ID: G774
Review Report on CACNA1B Target / Biomarker Content of Review Report on CACNA1B Target / Biomarker
CACNA1B
Other Name(s): calcium channel, voltage-dependent, N type, alpha 1B subunit | Voltage-dependent N-type calcium channel subunit alpha-1B | Voltage-gated calcium channel alpha subunit Cav2.2 | CACNL1A5 | NEDNEH | brain calcium channel III | Calcium channel, voltage-dependent, alpha 1B subunit, N type | Voltage-dependent N-type calcium channel subunit alpha-1B (isoform 1) | voltage-gated calcium channel subunit alpha Cav2.2 | voltage-dependent N-type calcium channel subunit alpha-1B-like | CAC1B_HUMAN | calcium channel, L type, alpha-1 polypeptide | Calcium channel, L type, alpha-1 polypeptide isoform 5 | Cav2.2 voltage-gated Ca2+ channel | Calcium channel, L type, alpha-1 polypeptide | Calcium channel alpha12.2 subunit | Brain calcium channel III | calcium channel alpha12.2 subunit | Calcium voltage-gated channel subunit alpha1 B, transcript variant 1 | DYT23 | CACNN | Voltage-gated calcium channel subunit alpha Cav2.2 | CACNA1B variant 1 | Calcium channel, N type | Cav2.2 | Calcium channel, voltage-dependent, L type, alpha 1B subunit | voltage-gated calcium channel alpha subunit Cav2.2 | calcium channel, voltage-dependent, L type, alpha 1B subunit | BIII | calcium voltage-gated channel subunit alpha1 B

Unlocking the Potential of Calcium Channel Modulators: A Focus on CACNA1B as a Drug Target and Biomarker

Introduction

Calcium channels are critical signaling molecules that regulate various physiological processes in the body, including muscle contractions, nerve impulses, and cell signaling. The calcium channel subunit CACNA1B has been identified as a potential drug target and biomarker due to its unique function and its ability to modulate cellular signaling pathways. In this article, we will provide an overview of CACNA1B, its function, potential drug targets, and future prospects as a drug development tool.

Function and Structure of CACNA1B

CACNA1B is a type-I calcium channel subunit that is expressed in most tissues and cells. It is a voltage-dependent channel that is known for its unique alpha 1B subunit, which is responsible for the regulation of channel opening and closing. The alpha 1B subunit is a transmembrane protein that contains a unique N-terminus and a unique C-terminus that are involved in the formation of the channel pore.

CACNA1B plays a vital role in various physiological processes, including muscle contractions, nerve impulses, and intracellular signaling. It is involved in the regulation of muscle contractions, which is critical for maintaining posture and movement. It is also involved in the regulation of nerve impulses , which is responsible for transmitting signals from the brain to the rest of the body. Additionally, CACNA1B is involved in the regulation of intracellular signaling pathways, which are critical for the regulation of cellular behavior and growth.

Potential Drug Targets

CACNA1B has been identified as a potential drug target due to its unique function and its ability to modulate cellular signaling pathways. One of the key potential drug targets for CACNA1B is the regulation of muscle contractions. Muscle contractions are critical for maintaining posture and movement, and any changes in muscle contractions can have a significant impact on an individual's quality of life.

Another potential drug target for CACNA1B is the regulation of nerve impulse. Nerve impulse is the basic way of transmitting information in the nervous system, and its transmission is regulated by many factors. CACNA1B plays an important role in regulating nervous impulses. Therefore, developing drugs to regulate the activity of CACNA1B may become a new idea for the treatment of neurodegenerative diseases.

Biomarker Potential

CACNA1B has also been identified as a potential biomarker due to its unique expression and its ability to modulate cellular signaling pathways. The expression of CACNA1B is regulated by various factors, including cytokines, chemokines, and intracellular signaling pathways. Therefore, the expression of CACNA1B can be used as a biomarker for various diseases, including neurodegenerative diseases, cancer, and cardiovascular diseases.

Future Prospects

The future prospects of CACNA1B as a drug target and biomarker are promising. CACNA1B has been shown to be involved in the regulation of various physiological processes, including muscle contractions, nerve impulses, and intracellular signaling pathways. Additionally, CACNA1B has been identified as a potential drug target due to its unique function and its ability to modulate cellular signaling pathways.

Conclusion

In conclusion, CACNA1B is a unique and critical protein that plays a vital role in various physiological processes. Its unique function and its ability to modulate cellular signaling pathways make it an attractive drug target and biomarker. The future prospects of CACNA1B as a drug target and biomarker is promising, and further research is needed to fully understand its function and its potential as a drug.

Protein Name: Calcium Voltage-gated Channel Subunit Alpha1 B

Functions: Voltage-sensitive calcium channels (VSCC) mediate the entry of calcium ions into excitable cells and are also involved in a variety of calcium-dependent processes, including muscle contraction, hormone or neurotransmitter release, gene expression, cell motility, cell division and cell death. This alpha-1B subunit gives rise to N-type calcium currents. N-type calcium channels belong to the 'high-voltage activated' (HVA) group. They are involved in pain signaling. Calcium channels containing alpha-1B subunit may play a role in directed migration of immature neurons. Mediates Ca(2+) release probability at hippocampal neuronal soma and synaptic terminals (By similarity)

The "CACNA1B Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about CACNA1B comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets

CACNA1C | CACNA1C-AS4 | CACNA1C-IT2 | CACNA1C-IT3 | CACNA1D | CACNA1E | CACNA1F | CACNA1G | CACNA1G-AS1 | CACNA1H | CACNA1I | CACNA1S | CACNA2D1 | CACNA2D1-AS1 | CACNA2D2 | CACNA2D3 | CACNA2D4 | CACNB1 | CACNB2 | CACNB3 | CACNB4 | CACNG1 | CACNG2 | CACNG2-DT | CACNG3 | CACNG4 | CACNG5 | CACNG6 | CACNG7 | CACNG8 | CACTIN | CACTIN-AS1 | CACUL1 | CACYBP | CAD | CADM1 | CADM2 | CADM3 | CADM3-AS1 | CADM4 | CADPS | CADPS2 | CAGE1 | CAHM | CALB1 | CALB2 | CALCA | CALCB | Calcium channel | Calcium release-activated channel (CRAC) | Calcium-activated chloride channel regulators | Calcium-Activated K(Ca) Potassium Channel | CALCOCO1 | CALCOCO2 | CALCR | CALCRL | CALCRL-AS1 | CALD1 | CALHM1 | CALHM2 | CALHM3 | CALHM4 | CALHM5 | CALHM6 | CALM1 | CALM2 | CALM2P1 | CALM2P2 | CALM3 | CALML3 | CALML3-AS1 | CALML4 | CALML5 | CALML6 | Calmodulin | CALN1 | Calpain | Calpain-13 | Calprotectin | CALR | CALR3 | CALU | CALY | CAMK1 | CAMK1D | CAMK1G | CAMK2A | CAMK2B | CAMK2D | CAMK2G | CAMK2N1 | CAMK2N2 | CAMK4 | CAMKK1 | CAMKK2 | CAMKMT | CAMKV | CAMLG | CAMP | cAMP Phosphodiesterase